文献速递外周动脉疾病

术前诊断小口径静脉旁路术在慢性肢体威胁性缺血中的作用

Role of Bypass with Preoperatively Diagnosed Small Caliber Veins in Chronic Limb-Threatening Ischemia.
PubMed 文献 · Ann Vasc Surg · 2021-02-04

本研究纳入95例WIfI 3/4期行腹股沟下旁路术的肢体,按术前静脉内径分为小口径(<2.5 mm,n=28)和足够口径(≥2.5 mm,n=67)组,评估伤口愈合相关结局。小口径组一期通畅率显著较差,但二期通畅率、伤口愈合率、伤口无复发率和无截肢生存率均相当。小口径静脉旁路术仍是实现伤口愈合的重要选择。

要点

  • 小口径静脉旁路术一期通畅率较差,但二期通畅率与足够口径组相当。
  • 小口径组伤口愈合率、无复发率及无截肢生存率与足够口径组无显著差异。
  • 在WIfI 3/4期CLTI患者中,小口径静脉仍可作为旁路移植物的选择。

核心结论

  • 小口径静脉旁路术虽一期通畅率较低,但若移植物保持通畅,伤口愈合率和无复发率与足够口径静脉相当。
  • 小口径静脉移植物是实现伤口愈合的重要选择。

研究设计与样本

  • 回顾性队列研究,纳入95例WIfI 3/4期行腹股沟下旁路术的肢体,按术前静脉内径<2.5 mm(小口径组,n=28)或≥2.5 mm(足够口径组,n=67)分组。
  • 采用倾向性评分匹配分析,纳入21对匹配肢体。

主要发现

  • 一期通畅率:小口径组显著劣于足够口径组(粗模型1年通畅率51.0% vs 82.1%,P=0.0003;匹配模型41.6% vs 77.7%,P=0.005)。
  • 二期通畅率:两组相当(粗模型1年通畅率83.1% vs 81.8%,P=0.26;匹配模型78.4% vs 77.7%,P=0.24)。
  • 1年伤口愈合率:两组相当(粗模型83.8% vs 87.0%,P=0.13;匹配模型61.4% vs 66.3%,P=0.65)。
  • 1年伤口无复发率:两组相当(粗模型100% vs 95.9%,P=0.71;匹配模型100% vs 100%,P=0.85)。
  • 1年无截肢生存率:两组相当(粗模型88.0% vs 87.2%,P=0.78;匹配模型78.6% vs 92.9%,P=0.38)。

临床怎么用

  • 对于WIfI 3/4期CLTI患者,术前超声评估为小口径静脉仍可考虑行旁路术。
  • 术后需密切监测移植物通畅性,必要时行二次干预以维持二期通畅。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In chronic limb-threatening ischemia (CLTI), although recent studies suggested that limbs classified as a higher Wound, Ischemia, foot Infection (WIfI) stage would benefit more from bypass surgery than endovascular therapy (EVT), graft unavailability is a major limitation for bypass. However, such graft unavailability is not clearly defined. This study aimed to assess whether bypass with veins judged as small by preoperative ultrasound is acceptable to achieve wound healing. METHODS: Ninety-five limbs classified as WIfI stage 3/4 that underwent infrainguinal bypass with veins were enrolled and divided into two groups based on the preoperative inner diameter of veins. Those with a diameter <2.5 mm were classified as small caliber grafts (SMGs, n=28) and those with a diameter ≥2.5 mm as sufficient caliber grafts (SUGs, n=67), and wound-related outcomes were evaluated. Wound healing rate (WHR) was analyzed in all cohort, and wound recurrence-free rate (WRF) and wound recurrence-free amputation-free survival rate (WRAFS) were calculated for limbs that achieved wound healing. A propensity score matched analysis was also performed to minimize the background difference, and 21 matched pairs were included for the analysis. RESULTS: Although the primary patency rate was significantly worse in SMGs (1-year patency, Crude model: 82.1% in SUGs and 51.0% in SMGs, P=0.0003; matched model: 77.7% in SUGs and 41.6% in SMGs, P = 0.005), the secondary patency rate was maintained in the equivalent level (1-year patency, Crude model: 81.8% in SUGs and 83.1% in SMGs, P=0.26; matched model: 77.7% in SUGs and 78.4% in SMGs, P = 0.24). One-year WHR was equivalent between the groups in both crude and matched models (Crude model: 87.0% in SUGs and 83.8% in SMGs, P=0.13; matched model: 66.3% in SUGs and 61.4% in SMGs, P = 0.65). One-year WRF and WRAFS were also equivalent (Crude model: WRF, 95.9% in SUGs and 100% in SMGs, P = 0.71; WRAFS, 87.2% in SUGs and 88.0% in SMGs, P = 0.78. Matched model: WRF, 100% in SUGs and 100% in SMGs, P = 0.85; WRAFS, 92.9% in SUGs and 78.6% in SMGs, P = 0.38). CONCLUSIONS: Although bypass with small caliber veins showed an inferior primary patency rate, WHR and WRF were equally good if grafts are maintained patent. Bypass with small caliber vein grafts would be an important option to achieve wound healing.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Miyake K, Nakamura T, Fujimura H, et al. Role of Bypass with Preoperatively Diagnosed Small Caliber Veins in Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2021. PMID: 33549802. doi:10.1016/j.avsg.2020.12.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。